US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Neuren Pharmaceuticals Limited (NEU) 銘柄情報

Neuren Pharmaceuticals Limited (NEU)

13.76

0.23

( 1.70% )

更新日時： 12:01:06

Neuren Pharmaceuticals Limited (NEU) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

13.76

( 1.70% )

買値

13.74

売値

13.76

出来高

65,232

13.61 日の範囲 13.85

11.00 52 週間の範囲 22.985

時価総額

前日終値

13.53

始値

13.73

時刻

最終取引時間

12:01:24

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 442,407

発行済株式数

126,323,976

配当利回り

PER

62.48

1 株当たり利益 (EPS)

0.23

歳入

64.65M

純利益

30.44M

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical tr... Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid; and in Phase 2 clinical trial for the treatment of Angelman and Pitt Hopkins. In addition, it develops NNZ-2591, which is in preclinical trial stage for the treatment of Prader-Willi syndrome, Hypoxic Ischemic Encephalopathy, and SYNGAP1. The company was incorporated in 2001 and is based in Hawthorn East, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.neurenpharma.com

本社

Hawthorn East, Australia

設立

2026

Neuren Pharmaceuticals Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker NEU. The last closing price for Neuren Pharmaceuticals was AUD13.53. Over the last year, Neuren Pharmaceuticals shares have traded in a share price range of AUD 11.00 to AUD 22.985.

Neuren Pharmaceuticals currently has 126,323,976 shares in issue. The market capitalisation of Neuren Pharmaceuticals is AUD1.74 billion. Neuren Pharmaceuticals has a price to earnings ratio (PE ratio) of 62.48.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.11	0.805860805861	13.65	14.58	12.52	338110	13.88309978	DE
4	1.07	8.43183609141	12.69	14.72	12.29	359538	13.34575789	DE
12	1.5	12.2349102773	12.26	14.72	11	359364	12.45916245	DE
26	-5.38	-28.1086729363	19.14	21.04	11	393954	14.10090249	DE
52	-0.11	-0.793078586878	13.87	22.985	11	443700	16.14796063	DE
156	0.75	5.76479631053	13.01	170.09	8.61	517863	15.37056116	DE
260	12.51	1000.8	1.25	170.09	1.24	450330	12.79716414	DE

NEU - Frequently Asked Questions (FAQ)

What is the current Neuren Pharmaceuticals Limited share price?

The current share price of Neuren Pharmaceuticals Limited is AUD 13.76

How many Neuren Pharmaceuticals Limited shares are in issue?

Neuren Pharmaceuticals Limited has 126,323,976 shares in issue

What is the market cap of Neuren Pharmaceuticals Limited?

The market capitalisation of Neuren Pharmaceuticals Limited is AUD 1.74B

What is the 1 year trading range for Neuren Pharmaceuticals Limited share price?

Neuren Pharmaceuticals Limited has traded in the range of AUD 11.00 to AUD 22.985 during the past year

What is the PE ratio of Neuren Pharmaceuticals Limited?

The price to earnings ratio of Neuren Pharmaceuticals Limited is 62.48

What is the cash to sales ratio of Neuren Pharmaceuticals Limited?

The cash to sales ratio of Neuren Pharmaceuticals Limited is 28.41

What is the registered address of Neuren Pharmaceuticals Limited?

The registered address for Neuren Pharmaceuticals Limited is 117 Camberwell Road, Hawthorn East, Victoria, 3123

What is the Neuren Pharmaceuticals Limited website address?

The website address for Neuren Pharmaceuticals Limited is www.neurenpharma.com

Which industry sector does Neuren Pharmaceuticals Limited operate in?

Neuren Pharmaceuticals Limited operates in the Biotechnology & Life Sciences sector

dinogreeves

dinogreeves 2分前

Meant to say, definitely not for you.

nowwhat2

nowwhat2 2分前

Basically ;

https://investorshub.advfn.com/uimage/uploads/2026/6/4/hehpnbtc_june_4_7d_8pm_BRUTAL_NERVOUS_X_4.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/4/hpzwzbtc_june_4_snip_8pm_see.jpg

Ooou812

Ooou812 5分前

Great. So Let’s make a deal then SK.

CA Market News

CA Market News 7分前

Hut 8 Announces Pricing of $4.25 Billion of Investment-Grade Senior Secured Notes for Beacon Point Data Center ProjectJune 4, 2026 11:03 PM
PR Newswire (US) Fully amortizing project financing due 2042; non-recourse to Hut 8 Corp. class="legendSpa

Oleblue

Oleblue 7分前

Cavitation Technologies, Inc. (OTCQB: CVAT): Virtual Investor Conferences

https://youtu.be/UDQErD6kWKI

Weekly Chart
https://schrts.co/nskswpXe

Achilles deFlandres

Achilles deFlandres 8分前

Pulte is good at cleaning house and doesn't seem to owe his soul to Neville Roy Singham or Reid Hoffman. We will see what happens. Every agency full of DTS District of Collectivists....

Major Profits

Major Profits 8分前

Schiff shorting Bitcoin? 🤷
AI Overview

Peter Schiff has not publicly confirmed that he is actively shorting Bitcoin with his own personal capital, but the outspoken gold advocate has persistently maintained a bearish stance on the cryptocurrency for years, frequently w

StockDetective

StockDetective 8分前

Definitely wouldn’t be with Larry & Chemist lol

rheddle

rheddle 9分前

They actually let it go below .001. It's been tough to hold for sure, but they have come through in the past.

Still waiting on the oil news, silver news etc.

Nothing much to cheer today though that's for sure.

Timing is HIRU's greatest weakness.

OracleWitch66

OracleWitch66 9分前

Going to need more eyes on FITY to gt that info flowing imo

22rover

22rover 12分前

Matt Klein appears to still be with https://sidechannel.com/about/team/

His LinkedIn profile also includes a Sidechannel banner.

Klein has a consulting firm, Big Fly, so it looks like he’s living that multiple hat lifestyle.

ProfitChaser

ProfitChaser 13分前

https://x.com/BebuzeeOfficial/status/2062528138303651935

Stockman1010101

Stockman1010101 13分前

Can someone fix this Navie's X web page. It says its gone on X.

dinogreeves

dinogreeves 16分前

Nice game. Almost lost that one.

https://investorshub.advfn.com/uimage/uploads/2026/6/4/plqpqScreenshot_2026-06-04_at_8.05.23%E2%80%AFPM.png

Oleblue

Oleblue 17分前

This $4 SpaceX Stock Is A Hidden Gem

https://youtu.be/azkY8W-hrhM

Stockman1010101

Stockman1010101 18分前

$7.86 is the close for tomorrow. Lets see If I am right?

skitahoe

skitahoe 19分前

No, they have two cleanroom suites, each suite has 10 individual cleanrooms. All cleanrooms are isolated from one another so 20 batches of vaccine can be made but a person moving from one to another must take the same precautions to avoid anything going from one cleanroom to another in the same sui

Bonvoy85

Bonvoy85 19分前

I dont see how it possibly drops below 3. Unless they somehow burn through 400 mil without making any progress on anything

FireMechanic

FireMechanic 20分前

Nice haircut on the price yesterday and today no trading volume from what I saw. WTF is going on here!!!

marzan

marzan 21分前

Kenyboy, where does it say the district court’s earlier ruling is reinstated. I only see it is remanded back to the district court.

The market may be overreacting to today’s SCOTUS reversal as if Amarin is suddenly out of options. Not necessarily. The Court remanded the case, which s

Jim37

Still here, holding and watching daily, but not watching every uptick/downtick. Only watching company news and larger scale trends/dynamics at this point

JJ24

Who picked up some $FRTG today ?

wronginvestor

wronginvestor 22分前

Hi Satter - I want to recheck your understanding here. My research says the stock is restricted for 12 months

Under SEC Rule 144(d)(1)(i), a 6-month holding period is granted only to companies that are subject to the reporting requirements of Section 13 or 15(d) of the Securities Exch

Juststoppingby

Juststoppingby 25分前

I contacted them a couple of weeks ago, and they responded within a couple of hours.
I liked their response, and it also shows me they are working on things behind the scenes, even if we don't see it. It also raised more questions for me that they did not respond to, as I expected.
It

Neuren Pharmaceuticals

Cheniere Energy

Cytek BioSciences

DJ US Gambling Total Sto...

CUP vs US Dollar

Green Impact Partners

Fresenius SE & Co KGaA

Lancaster Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。